Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
36,531,198
-
Share change
-
+795,260
-
Total reported value
-
$305,130,909
-
Price per share
-
$8.36
-
Number of holders
-
37
-
Value change
-
+$6,927,423
-
Number of buys
-
14
-
Number of sells
-
13
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q1 2021
As of 31 Mar 2021 Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,531,198 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, Abingworth LLP, Aisling Capital Management LP, Samsara BioCapital, LLC, and Foresite Capital Management III, LLC.
This table shows 36 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.